Company Filing History:
Years Active: 2008-2010
Title: Jürg Tschopp: Innovator in Fusion Proteins
Introduction
Jürg Tschopp is a notable inventor based in Epalinges, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. With a total of two patents to his name, Tschopp's work has the potential to impact medical science and therapeutic applications.
Latest Patents
Tschopp's latest patents include innovative designs for fusion constructs containing active sections on TNF ligands. One patent discloses a recombinant fusion protein that comprises an Fc section of an immunoglobulin and the extracellular part of a TNF ligand. This invention aims to enhance the functionality of therapeutic proteins. Another patent focuses on oligomers of recombinant fusion proteins, which can form dimers, trimers, quadromers, or pentamers. These oligomers are characterized by their ability to dimerize or oligomerize without the action of third-party molecules, making them valuable for producing medicaments.
Career Highlights
Throughout his career, Tschopp has worked with various companies, including Apotech Research and Development Ltd. and Apoxis S.A. His experience in these organizations has contributed to his expertise in the field of biotechnology and fusion protein development.
Collaborations
Tschopp has collaborated with notable professionals in his field, including Pascal Schneider and Nils Holler. These collaborations have likely enriched his research and innovation efforts.
Conclusion
Jürg Tschopp is a distinguished inventor whose work in fusion proteins has the potential to advance medical therapies. His patents reflect a commitment to innovation in biotechnology, and his collaborations further enhance his contributions to the field.